Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03655782 · ClinicalTrials.gov registry record · NA

Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury

A NA study of mTBI - Mild Traumatic Brain Injury, sponsored by Perception Dynamics Institute.

Active
Registry status
NA
Development phase
90
Enrollment target
2
Study locations

NCT03655782: Active NA study of mTBI - Mild Traumatic Brain Injury, sponsored by Perception Dynamics Institute.

NCT03655782 is a NA study of mTBI - Mild Traumatic Brain Injury that is active but no longer recruiting, run by Perception Dynamics Institute. The registered enrollment target is 90 participants, below the 216-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03655782, a NA study of mTBI - Mild Traumatic Brain Injury, is active but no longer recruiting, sponsored by Perception Dynamics Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
2
Study locations

Study Summary

The proposed study tests the efficacy (Phase II) of 36 30-minute training sessions of PATH neurotraining followed by digit memory exercises to improve working memory, processing speed and attention in mTBI patients rapidly and effectively to provide clinical testing of a therapeutic training for the remediation of cognitive disorders caused by a concussion. This study will contribute to the fundamental knowledge of how to remediate concussions from a mTBI to enhance the health, lengthen the life and reduce the disabilities that result from a mTBI.

Primary Outcome

Visual Working Memory (VWM) using Test of Information Processing Skills (TIPS), having two distractor tasks to measure Sequential Processing: the subject must remember a sequence of letters, that are shown one at a time for 2 seconds each, for sequences of from 2 up to 9 letters right after seeing the entire sequence of letters. Short Term that are shown one at a time for 2 seconds each, for sequences of from 2 up to 9 letters right after seeing the entire sequence of letters. Short Term VWM is

Interventions

  • BEHAVIORAL PATH + DigitMemory (DM) neurotraining

Study Locations (2)

California

  • University of California at San Diego - San Diego
  • Perception Dynamics Institute - Solana Beach

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-07-01
Est. Completion 2029-09-30
Phase NA
Perception Dynamics Institute

1 total trials

What the registry record for NCT03655782 still lists

NCT03655782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 216-participant average among 6 other mTBI - Mild Traumatic Brain Injury trials with a reported enrollment target (58% lower).

The record links to 1 condition, with mTBI - Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which PATH + DigitMemory (DM) neurotraining is the first listed.

NCT03655782 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03655782 about?

NCT03655782 is a clinical study titled "Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury". The proposed study tests the efficacy (Phase II) of 36 30-minute training sessions of PATH neurotraining followed by digit memory exercises to improve working memory, processing speed and attention in mTBI patients rapidly and effectively to provide clinical testing of a therapeutic training for the...

What is the current status of trial NCT03655782?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-07-01. Estimated completion is 2029-09-30.

What conditions does trial NCT03655782 study?

This clinical trial studies the following conditions: mTBI - Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT03655782?

The interventions under investigation include: PATH + DigitMemory (DM) neurotraining (BEHAVIORAL).

Who is sponsoring clinical trial NCT03655782?

This trial is sponsored by Perception Dynamics Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03655782 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for mTBI - Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03655782, the US trial registry maintained by the National Library of Medicine. NCT03655782 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.